March 28, 2020
Neurotrophic Keratitis

Neurotrophic Keratitis Market is growing at a CAGR of 5.02%

The global market for neurotrophic keratitis is expected to expand to CAGR by 5.2% from 2019 to 2027.

Ophthalmologists are currently using the Nerve Growth Factor (NGF) healing pathway, a neurotrophin that initiates the neuronal germination of injured and intact neurons, a landmark discovery made by R Levi Montalcini, a Nobel laureate. Human cornea produces high-affinity NGF receptors, which play an important role in stimulating the survival and spread of epithelial and nerve fibres. Oxervate follows this pathway for the treatment of neurotrophic keratitis across all age groups.

Access Free Sample Copy of Research Report: https://www.credenceresearch.com/sample-request/59723

[Note: Our Free Complimentary Sample Report Accommodate a Brief Introduction To The Synopsis, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology are also Included]

For Any Query, Ask Our Expert at https://www.credenceresearch.com/inquiry-before-buying/59723

Neurotrophic keratitis is an orphan disease with a global prevalence of 5 per 10,000 people. The damage to the trigeminal nerve nucleus present in the corneal region of the eye causes damage to the healing process of corneal injuries. The treatment approach is adopted according to the different stages of the disease. Artificial tears are recommended in all phases to ensure the wetness, cleanliness and lubrication of the corneal surface. Topical antibiotics are prescribed as a preventive measure against bacterial infection in stage 2 of the disease. The treatment of corneal ulcers is preferred in stage 3 surgical procedures such as Tarsorraphy and amniotic membrane transplantation. The recent approval by Oxervate of the recombinant human nerve growth factor EMA and USFDA will strengthen the growth of the neurotrophic market during the forecast period.

North America is responsible for 33% of the market share and is currently the largest regional segment in the market for neurotrophic keratitis. According to research findings from the American Academy of Ophthalmology (AAO), approximately 65,000 U.S. citizens are reported to suffer from neurotrophic keratitis. Affordable reimbursement scenario is driving the growth of the market for neurotrophic keratitis in the North American region. Europe is trailing North America, accounting for 28.5 per cent of market growth mainly due to the strategic collaboration between academic research institutes and pharmaceutical giants to develop novel drugs for the treatment of neurotrophic keratitis. The European Medical Agency (EMA) has granted the status of orphan disease to neurotrophic keratitis and has accelerated the development and sale of drug propaganda in the EU market. The Asia Pacific has a market share of 16% due to an increasing prevalence of neurotrophic keratitis in the geriatric population and a sharp increase in ophthalmology in the region over the last decade.

Pharmaceutical companies specializing in the treatment of neurotrophic keratitis are Allergan, Plc., Abbott Laboratories, Inc., Bausch & Lomb Incorporated, Bayer AG, CooperVision, Dompe farmaceutici S.p. A., Johnson & Johnson, Novartis AG, ReGenTree, LLC., and Walgreens.

Key questions answered in this report

  • Which strategic collaboration, merger and acquisitions are taking place in the neurotrophic keratitis market?
  • Which key players are manufacturing medicines for the treatment of neurotrophic keratitis market?
  • What is the disease etiology of neurotrophic keratitis and medicines prescribed as per the different stages of the disease?
  • What is Oxervate and how will it perform during the forecast period?
  • What will be the market performance of developing regions such as Asia Pacific and Latin America in the neurotrophic keratitis market?

Access Free Sample Copy of Research Report: https://www.credenceresearch.com/sample-request/59723

[Note: Our Free Complimentary Sample Report Accommodate a Brief Introduction To The Synopsis, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology are also Included]

Leave a Reply

Your email address will not be published. Required fields are marked *